We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Copeptin Changes After Food Intake (CoMeal)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01772914
First Posted: January 21, 2013
Last Update Posted: May 20, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mirjam Christ-Crain, University Hospital, Basel, Switzerland
  Purpose
The purpose of this study is to determine whether copeptin levels are affected by food intake.

Condition
Healthy Adults Copeptin

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test

Resource links provided by NLM:


Further study details as provided by Mirjam Christ-Crain, University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid [ Time Frame: 30, 60, 90, 120, 180 minutes after intake of the test liquids ]

Biospecimen Description:
Serum EDTA

Enrollment: 30
Study Start Date: February 2013
Study Completion Date: February 2014
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
healthy adults
Criteria

Inclusion Criteria:

  • Aged over 18 years

Exclusion Criteria:

  • Intake of any kind of medication (except birth control pill)
  • BMI >30 kg/m2
  • Evidence of any acute illness
  • History of chronic illness
  • Pregnancy
  • Known galactosemia or maltose malabsorption
  • Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01772914


Locations
Switzerland
University Hospital Basel
Basel, Basel-Stadt, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Principal Investigator: Mirjam Christ-Crain, Prof.Dr.med.
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Mirjam Christ-Crain, Prof. Dr. med., University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01772914     History of Changes
Other Study ID Numbers: CoMeal 2013
First Submitted: January 17, 2013
First Posted: January 21, 2013
Last Update Posted: May 20, 2014
Last Verified: January 2013

Keywords provided by Mirjam Christ-Crain, University Hospital, Basel, Switzerland:
Copeptin
eating
glucose tolerance test
mixed meal test
physiological

Additional relevant MeSH terms:
Diabetes Insipidus
Kidney Diseases
Urologic Diseases
Pituitary Diseases
Endocrine System Diseases
Arginine Vasopressin
Hemostatics
Coagulants
Vasoconstrictor Agents
Antidiuretic Agents
Natriuretic Agents
Physiological Effects of Drugs